NDV-HXP-S (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "NDV-HXP-S" in English language version.

refsWebsite

Global rank English rank

4clinicaltrials.gov

5,225^th place

4,062^nd place

4nih.gov

4^th place

2doi.org

2^nd place

1butantan.gov.br

low place

1reuters.com

49^th place

47^th place

1thaipbsworld.com

low place

1thelogisticsworld.com

low place

1nytimes.com

7^th place

1harvard.edu

18^th place

17^th place

1utexas.edu

916^th place

706^th place

1bangkokpost.com

1,173^rd place

795^th place

1vietnamnews.vn

low place

8,328^th place

1globo.com

62^nd place

304^th place

bangkokpost.com

Wipatayotin A (11 February 2021). "Thai-made vaccine ready 'by next year'". Bangkok Post. Bangkok Post Public Company Limited. Retrieved 9 April 2021.

butantan.gov.br

"Butantan vai desenvolver e produzir nova vacina contra a Covid-19; testes clínicos da ButanVac devem começar em abril". butantan.gov.br (in Portuguese). Retrieved 16 December 2021.

clinicaltrials.gov

"Study of a Live rNDV Based Vaccine Against COVID-19". ClinicalTrials.gov. United States National Library of Medicine. 4 May 2021. NCT04871737. Retrieved 4 May 2021.
"Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil (ADAPTCOV)". clinicaltrials.gov. United States National Library of Medicine. 6 August 2021. Retrieved 6 August 2021.
"A Phase 1/2 Safety and Immunogenicity Trial of COVID-19 Vaccine COVIVAC". clinicaltrials.gov. United States National Library of Medicine. April 2021. Retrieved 9 April 2021.
Clinical trial number NCT04764422 for "Assess the Safety and Immunogenicity of NDV-HXP-S Vaccine in Thailand" at ClinicalTrials.gov

doi.org

Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, et al. (December 2020). "Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate". eBioMedicine. 62: 103132. doi:10.1016/j.ebiom.2020.103132. PMC 7679520. PMID 33232870.
Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, et al. (September 2020). "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes". Science. 369 (6510): 1501–1505. Bibcode:2020Sci...369.1501H. doi:10.1126/science.abd0826. PMC 7402631. PMID 32703906.

globo.com

g1.globo.com

"Desenvolvimento da Butanvac é suspenso após vacina não atingir resultados nos estudos de fase 2". G1 (in Brazilian Portuguese). 23 August 2024. Retrieved 26 August 2024.

harvard.edu

ui.adsabs.harvard.edu

Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, et al. (September 2020). "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes". Science. 369 (6510): 1501–1505. Bibcode:2020Sci...369.1501H. doi:10.1126/science.abd0826. PMC 7402631. PMID 32703906.

nih.gov

ncbi.nlm.nih.gov

Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, et al. (December 2020). "Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate". eBioMedicine. 62: 103132. doi:10.1016/j.ebiom.2020.103132. PMC 7679520. PMID 33232870.
Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, et al. (September 2020). "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes". Science. 369 (6510): 1501–1505. Bibcode:2020Sci...369.1501H. doi:10.1126/science.abd0826. PMC 7402631. PMID 32703906.

pubmed.ncbi.nlm.nih.gov

Sun W, Leist SR, McCroskery S, Liu Y, Slamanig S, Oliva J, et al. (December 2020). "Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate". eBioMedicine. 62: 103132. doi:10.1016/j.ebiom.2020.103132. PMC 7679520. PMID 33232870.
Hsieh CL, Goldsmith JA, Schaub JM, DiVenere AM, Kuo HC, Javanmardi K, et al. (September 2020). "Structure-based design of prefusion-stabilized SARS-CoV-2 spikes". Science. 369 (6510): 1501–1505. Bibcode:2020Sci...369.1501H. doi:10.1126/science.abd0826. PMC 7402631. PMID 32703906.

nytimes.com

Zimmer C (5 April 2021). "Researchers Are Hatching a Low-Cost Coronavirus Vaccine". The New York Times. Retrieved 7 April 2021.

reuters.com

Simões E, Fonseca P (26 March 2021). "Brazil posts record 3,650 new COVID-19 deaths, unveils two homegrown vaccines". Reuters. Retrieved 7 April 2021. Earlier, Sao Paulo's Butantan biomedical institute said it will seek approval ... Butantan aims to produce 40 million doses of the Butanvac vaccine ... The vaccine was developed using a modified virus, which causes the Newcastle disease in birds ...

thaipbsworld.com

"Mahidol-GPO's human trials of its COVID-19 vaccine show promising results". Thai PBS World. 1 July 2021. Retrieved 19 July 2021.

thelogisticsworld.com

Juarez C (22 April 2021). "Vacuna Patria: esto es lo que se sabe de su avance y eventual producción". The Logistics World. Retrieved 24 June 2021.

utexas.edu

news.utexas.edu

Airhart M (5 April 2021). "Human Trials Begin for a Low-Cost COVID-19 Vaccine to Extend Global Access". University of Texas. Retrieved 7 April 2021.

vietnamnews.vn

"Việt Nam's COVID vaccine developer stops third phase trial due to volunteers shortage". vietnamnews.vn. Retrieved 12 February 2023.